Claude La Rivière

Croqueur/Compositeur d'images



 


 

 

BIENVENUE DANS MON UNIVERS
 
Vos yeux sont mes ailes 
 
 
 
 
 
Ult to completely remove with surgery and the currently available chemotherapy is unable to eradiate all of the remaining cancer. Both optimal cytoreductive surgery and platinum-based chemotherapy prolong the time to cancer recurrence and improve overall survival. Cytoreductive surgery during cytoreductive surgery, physicians attempt to remove as much of the ovarian cancer as possible. Cytoreductive surgery is beneficial because it reduces the number of cancer cells that ultimately need to be destroyed by chemotherapy and therefore, decreases the likelihood of the cancer developing a resistance to chemotherapy. Initial cytoreductive surgery in ovarian cancer is currently considered the standard of care because clinical studies have shown that patients who have had optimal cytoreductive surgery live longer and have a more prolonged time to cancer recurrence than patients who have had suboptimal cytoreductive surgery. [1] following cytoreductive surgery, all patients with stage iv ovarian cancer are offered additional treatment. This is because the majority of patients will experience recurrence of their cancer even after complete surgical resection. Nearly all patients with stage iv disease have cancer that was not removed by surgery. An effective treatment is needed to eliminate the remaining cancer in order to improve the outcome achieved with surgical removal of the cancer. Currently, this treatment is chemotherapy. viagra online buy cheap viagra buy viagra online viagra online viagra for sale cheap viagra online generic viagra online cheap viagra online cheap viagra buy viagra Chemotherapy for stage iv ovarian cancer clinical trials have demonstrated that for patients with advanced ovarian cancer, treatment with combination chemotherapy regimens containing a platinum (platinolâ® or paraplatinâ®) compound prolongs the duration of survival and prevents more recurrences of cancer compared to treatment with surgery and non-platinum compounds. Chemotherapy typically consists of paclitaxel and a platinum compound administered every 3 weeks for 6-8 cycles. Chemotherapy is most often given after surgery. In some cases, however, it may be given both before and after surgery. Giving chemotherapy before surgery may reduce the amount of cancer, thereby allowing for more complete surgical removal of the cancer. This approach to treatment remains controversial, but it may be considered for selected patients with advanced disease who do not appear to be.
 
viagra viagra difference